|
MANBA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.850100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.638000E-01 |
| Normal-vs-Stage2 |
8.260000E-02 |
| Normal-vs-Stage3 |
3.413400E-01 |
| Normal-vs-Stage4 |
7.518200E-01 |
| Stage1-vs-Stage2 |
1.056050E-01 |
| Stage1-vs-Stage3 |
3.492800E-01 |
| Stage1-vs-Stage4 |
7.800400E-01 |
| Stage2-vs-Stage3 |
5.471800E-01 |
| Stage2-vs-Stage4 |
6.965400E-01 |
| Stage3-vs-Stage4 |
9.273200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.101600E-02 |
| Normal-vs-AfricanAmerican |
1.133160E-01 |
| Normal-vs-Asian |
6.544400E-01 |
| Caucasian-vs-AfricanAmerican |
5.036000E-01 |
| Caucasian-vs-Asian |
8.410400E-01 |
| AfricanAmerican-vs-Asian |
9.400200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.104600E-01 |
| Normal-vs-Female |
1.103560E-03 |
| Male-vs-Female |
3.879200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.819000E-01 |
| Normal-vs-Extreme_Weight |
8.550200E-01 |
| Normal-vs-Obese |
5.602000E-02 |
| Normal-vs-Extreme_Obese |
9.598400E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.507600E-01 |
| Normal_Weight-vs-Obese |
7.083000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.144200E-01 |
| Extreme_Weight-vs-Obese |
8.392300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.772200E-01 |
| Obese-vs-Extreme_Obese |
4.104000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.514220E-01 |
| Normal-vs-Age(41-60Yrs) |
1.288030E-01 |
| Normal-vs-Age(61-80Yrs) |
1.831770E-01 |
| Normal-vs-Age(81-100Yrs) |
1.451410E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.722200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.023200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.609600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.878600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.312800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.472600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.933600E-01 |
| Normal-VS-Type2 PRCC |
3.101000E-01 |
| Normal-VS-KIRP CIMP |
1.231850E-01 |
| Normal-VS-Unclassified PRCC |
7.997400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.364600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.613200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.951660E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.414300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.282300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.277000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.858000E-01 |
| Normal-vs-N1 |
1.247770E-01 |
| Normal-vs-N2 |
4.056600E-01 |
| N0-vs-N1 |
1.793040E-01 |
| N0-vs-N2 |
3.205800E-01 |
| N1-vs-N2 |
9.526600E-01 |
|
|
